home / stock / lixt / lixt news

LIXT News and Press, Lixte Biotechnology Holdings Inc. From 07/18/23

Stock Information
Company Name: Lixte Biotechnology Holdings Inc.
Stock Symbol: LIXT
Market: OTC
Website: lixte.com
Menu
LIXT LIXT Quote LIXT Short LIXT News LIXT Articles LIXT Message Board
Get LIXT Alerts

News, Short Squeeze, Breakout and More Instantly...
LIXT - LIXTE Biotechnology Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules

PASADENA, CA, July 18, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”) today announced it has entered into a securities purchase agreement with a single health-care focused, institutional investor for...
LIXT - RMTI, QSI and BNED among mid-day movers

2023-07-17 13:40:37 ET Gainers: BridgeBio Pharma BBIO +78% . Acumen Pharmaceuticals ABOS +64% . GreenPower Motor Company GP +41% . Prestige Wealth PWM +39% . Quantum-Si incorporated ( QSI ) +35% . Lixte Biotechnology Holdings ( LIXT ) ...

LIXT - Preclinical Results of LIXTE Biotechnology's Collaboration with Netherlands Cancer Institute Reveal Novel Mechanism by which LIXTE's Lead Clinical Compound LB-100 Enhances Effectiveness of Immunotherapy and Chemotherapy

Results Provide Striking Molecular Evidence that I nhibiting PP2A with LB -100 Sensitizes Cancer Cells to Immunotherapy and Chemotherapy PASADENA, CA, July 17, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (&#x...

LIXT - LIXTE Biotechnology regains compliance with Nasdaq listing standards

2023-06-23 08:58:45 ET LIXTE Biotechnology ( NASDAQ: LIXT ) said on Friday that it had received a Nasdaq notice on regaining compliance with stock exchange's minimum bid price requirement. The company was notified of non-compliance last year on June 24 with...
LIXT - LIXTE Biotechnology Holdings, Inc. Regains Compliance with Nasdaq Continued Listing Requirements

PASADENA, CA, June 23, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ( Nasdaq: LIXT ) (“LIXTE” or the “Company”) announced today that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that it has regained compl...

LIXT - MRKR, TMC and SIEN among mid-day movers

2023-06-16 14:00:02 ET Gainers: Evelo Biosciences ( EVLO ) +120% . Sientra ( SIEN ) +29% . TMC the metals company ( TMC ) +24% . ICZOOM Group ( IZM ) +20% . iRobot Corporation ( IRBT ) +20% . Marker Therapeutics ( MRKR ) ...

LIXT - LIXTE Biotechnology and the Spanish Sarcoma Group Enroll First Patient in a Phase 1b/2 Randomized Trial of Doxorubicin +/- LIXTE's Lead Anti-Cancer Compound, LB-100, in Advanced Soft Tissue Sarcomas

PASADENA, CA, June 07, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ( Nasdaq: L IXT ) (“LIXTE”), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, today announced the en...
LIXT - LIXTE Biotechnology Holdings announces reverse stock split to obtain minimum price compliance

2023-06-02 14:49:11 ET LIXTE Biotechnology Holdings ( NASDAQ: LIXT ) has announced that it will effect a 1-for-10 reverse stock split of its issued and outstanding common stock effective on Friday, June 2, 2023. The Company’s common stock will trade on a post-split basi...

LIXT - LIXTE Biotechnology Holdings, Inc. Announces 1-for-10 Reverse Stock Split of its Common Stock Effective on Pre-Market Opening on June 5, 2023

PASADENA, CA, June 02, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) ( Nasdaq: LIXT ) announced today that it will effect a 1-for-10 reverse stock split of its issued and outstanding common stock effective on Friday, ...

LIXT - Recently Published Independent Research Reveals New Mechanisms by Which LIXTE Biotechnology's Lead Clinical Compound, LB-100, Increases Effectiveness of Cancer Immunotherapy

Results A dd to G rowing Body of E vidence that I nhibiting PP2A with LB - 100 M ay B e a General Method for Enhancing the Effectiveness of Immunotherapy in Refractory Cancers PASADENA, CA, May 30, 2023 (GLOB...
Previous 10 Next 10